Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection
出版年份 2022 全文链接
标题
Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection
作者
关键词
-
出版物
Viruses-Basel
Volume 14, Issue 3, Pages 651
出版商
MDPI AG
发表日期
2022-03-22
DOI
10.3390/v14030651
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunogenicity and safety of the BNT162b2 COVID‐19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy
- (2022) Eugenio Milano et al. JOURNAL OF MEDICAL VIROLOGY
- Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection—A comparative study from Novi Sad, Serbia
- (2022) Vladimir Petrović et al. PLoS One
- Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China
- (2022) Xiaojie Huang et al. Viruses-Basel
- Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
- (2022) Ariel Israel et al. Vaccines
- Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
- (2022) Zabrina L. Brumme et al. npj Vaccines
- SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
- (2021) Gregory J. Walker et al. Viruses-Basel
- Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
- (2021) Adam K. Wheatley et al. Nature Communications
- Assessment of salivary antibody response to BNT162b2 mRNA COVID‐19 vaccination
- (2021) Ivana Lapić et al. JOURNAL OF MEDICAL VIROLOGY
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study
- (2021) Matthew A Spinelli et al. Lancet HIV
- Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV
- (2021) Jake A. Ruddy et al. AIDS
- The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)
- (2021) Bezawit A Woldemeskel et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
- (2021) Itzchak Levy et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibody titers and protection against a SARS-CoV-2 infection
- (2021) Chloé Dimeglio et al. JOURNAL OF INFECTION
- Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
- (2021) Hana M. El Sahly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human IgG and IgA responses to COVID-19 mRNA vaccines
- (2021) Adam V. Wisnewski et al. PLoS One
- Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
- (2021) Kizzmekia S. Corbett et al. SCIENCE
- COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
- (2021) Pinja Jalkanen et al. Nature Communications
- Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
- (2021) Matthias Becker et al. Nature Communications
- Brief Report: Humoral and cellular immune responses to SARS‐CoV‐2 infection and vaccination in B cell depleted autoimmune patients
- (2021) David Simon et al. Arthritis & Rheumatology
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
- (2021) John Frater et al. Lancet HIV
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
- (2021) Shabir A Madhi et al. Lancet HIV
- Humoral response to SARS-CoV-2 vaccines in people living with HIV
- (2021) Sebastian Noe et al. INFECTION
- Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV
- (2021) Zhengchao Lv et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
- (2021) Mark A Brockman et al. JOURNAL OF INFECTIOUS DISEASES
- Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation
- (2021) A.M.M. Murillo et al. SENSORS AND ACTUATORS B-CHEMICAL
- Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
- (2021) Aljawharah Alrubayyi et al. Nature Communications
- Impact of cytokine inhibitor therapy on the prevalence, seroconversion rate and longevity of the humoral immune response against SARS‐CoV ‐2 in an unvaccinated cohort
- (2021) David Simon et al. Arthritis & Rheumatology
- Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
- (2021) Lorenzo Azzi et al. EBioMedicine
- Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies
- (2020) Kathleen G. Beavis et al. JOURNAL OF CLINICAL VIROLOGY
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
- (2020) Chee Wah Tan et al. NATURE BIOTECHNOLOGY
- Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
- (2020) David Simon et al. Nature Communications
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- (2020) Zijun Wang et al. Science Translational Medicine
- ELISA detection of SARS-CoV-2 antibodies in saliva
- (2020) Melanie A. MacMullan et al. Scientific Reports
- Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
- (2020) Carlo Cervia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease
- (2019) Antigoni Morou et al. NATURE IMMUNOLOGY
- Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living with and without HIV in the Veterans Aging Cohort Study
- (2018) Kellie L. Hawkins et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Immune reconstitution and vaccination outcome in HIV-1 infected children
- (2012) Alberto Cagigi et al. Human Vaccines & Immunotherapeutics
- Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy
- (2009) Alessandra Viganò et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count
- (2009) Michael L. Landrum et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now